Product NDC: | 66658-234 |
Proprietary Name: | Kineret |
Non Proprietary Name: | anakinra |
Active Ingredient(s): | 100 mg/.67mL & nbsp; anakinra |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 66658-234 |
Labeler Name: | Swedish Orphan Biovitrum AB (publ) |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA103950 |
Marketing Category: | BLA |
Start Marketing Date: | 20091215 |
Package NDC: | 66658-234-28 |
Package Description: | 4 CARTON in 1 CASE (66658-234-28) > 7 SYRINGE, GLASS in 1 CARTON (66658-234-07) > .67 mL in 1 SYRINGE, GLASS (66658-234-01) |
NDC Code | 66658-234-28 |
Proprietary Name | Kineret |
Package Description | 4 CARTON in 1 CASE (66658-234-28) > 7 SYRINGE, GLASS in 1 CARTON (66658-234-07) > .67 mL in 1 SYRINGE, GLASS (66658-234-01) |
Product NDC | 66658-234 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | anakinra |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 20091215 |
Marketing Category Name | BLA |
Labeler Name | Swedish Orphan Biovitrum AB (publ) |
Substance Name | ANAKINRA |
Strength Number | 100 |
Strength Unit | mg/.67mL |
Pharmaceutical Classes | Interleukin 1 Receptor Antagonists [MoA],Interleukin-1 Receptor Antagonist [EPC] |